PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 91 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 42.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $184,000 | -62.9% | 35,592 | -72.5% | 0.00% | -50.0% |
| Q2 2021 | $496,000 | +1277.8% | 129,608 | +643.6% | 0.00% | – |
| Q3 2020 | $36,000 | -80.6% | 17,429 | -78.7% | 0.00% | -100.0% |
| Q1 2020 | $186,000 | +14.8% | 81,758 | +82.7% | 0.01% | +400.0% |
| Q4 2019 | $162,000 | +217.6% | 44,761 | +314.5% | 0.00% | – |
| Q2 2019 | $51,000 | -64.3% | 10,800 | -61.8% | 0.00% | -100.0% |
| Q2 2018 | $143,000 | +15.3% | 28,300 | +55.5% | 0.00% | 0.0% |
| Q1 2018 | $124,000 | -69.2% | 18,200 | -65.8% | 0.00% | -71.4% |
| Q4 2017 | $402,000 | – | 53,260 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |